Literature DB >> 12729901

Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition.

Mi Ra Jeong1, Ryota Hashimoto, Vladimir V Senatorov, Koichiro Fujimaki, Ming Ren, Min Soo Lee, De-Maw Chuang.   

Abstract

We studied the neuroprotective effects of valproic acid (VPA), a primary mood stabilizer and anticonvulsant, in cultured rat cerebral cortical neurons (CCNs). CCNs underwent spontaneous cell death when their age increased in culture. As shown by mitochondrial activity and calcein-AM assays, treatment of CCNs with VPA starting from day 9 in vitro markedly increased viability and prolonged the life span of the cultures. The neuroprotective action of VPA was time-dependent and occurred at therapeutic levels with a maximal effect at about 0.5 mM. LiCl (1 mM) also protected CCNs from aging-induced, spontaneous cell death but less effectively. VPA-induced neuroprotection in aging CCN cultures was associated with a robust increase in histone H3 acetylation levels and the protective effect was mimicked by treatment with a histone deacetylase inhibitor, trichostatin A, but not by VPA analogs which are inactive in blocking histone deacetylase. Our results suggest a role of histone deacetylase inhibition in mediating the neuroprotective action of VPA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729901     DOI: 10.1016/s0014-5793(03)00350-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  Effect of valproic acid on mitochondrial epigenetics.

Authors:  Hu Chen; Svetlana Dzitoyeva; Hari Manev
Journal:  Eur J Pharmacol       Date:  2012-06-20       Impact factor: 4.432

2.  Distribution of histone deacetylases 1-11 in the rat brain.

Authors:  Ron S Broide; Jeff M Redwine; Najla Aftahi; Warren Young; Floyd E Bloom; Christopher J Winrow
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

3.  Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.

Authors:  Yavuz Dodurga; Gulsah Gundogdu; Volkan Tekin; Tugba Koc; N Lale Satiroglu-Tufan; Gulseren Bagci; Vural Kucukatay
Journal:  Mol Biol Rep       Date:  2014-03-21       Impact factor: 2.316

4.  Epigenetics in mood disorders.

Authors:  Patrick O McGowan; Tadafumi Kato
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

5.  Valproic acid-mediated inhibition of trimethyltin-induced deficits in memory and learning in the rat does not directly depend on its anti-oxidant properties.

Authors:  M A Edalatmanesh; M Hosseini; S Ghasemi; S Golestani; H R Sadeghnia; S M Mousavi; F Vafaee
Journal:  Ir J Med Sci       Date:  2015-02-01       Impact factor: 1.568

6.  Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.

Authors:  Jitendriya Mishra; Tanya Chaudhary; Anil Kumar
Journal:  Neurotox Res       Date:  2014-02-25       Impact factor: 3.911

Review 7.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

Review 8.  Multiple roles of HDAC inhibition in neurodegenerative conditions.

Authors:  De-Maw Chuang; Yan Leng; Zoya Marinova; Hyeon-Ju Kim; Chi-Tso Chiu
Journal:  Trends Neurosci       Date:  2009-09-21       Impact factor: 13.837

9.  Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).

Authors:  Kennichi C Dowdell; Lesley Pesnicak; Victoria Hoffmann; Kenneth Steadman; Alan T Remaley; Jeffrey I Cohen; Stephen E Straus; V Koneti Rao
Journal:  Exp Hematol       Date:  2009-02-12       Impact factor: 3.084

10.  Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.

Authors:  Barbara Monti; Valentina Gatta; Francesca Piretti; Simonetta S Raffaelli; Marco Virgili; Antonio Contestabile
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.